MedTrace Logo

Gender Identity and Own Body Perception

NCT04374708 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2023-03-22

No results posted yet for this study

Summary

This study will provide valuable information on the neurobiological underpinning of gender dysphoria (GD) and the effects of sex hormones, and promises to uncover functional or structural neural patterns that could predict outcome in terms of body image and quality of life after cross-sex hormone treatment.

Conditions

  • Gender Dysphoria

Interventions

DIAGNOSTIC_TEST

fMRI

fMRI: body morph test and neurocognitive testing

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-22
Primary Completion
2021-02-01
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04374708 on ClinicalTrials.gov